Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Abbvie Inc (ABBV)
Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 315,252,000
  • Shares Outstanding, K 1,800,000
  • Annual Sales, $ 54,318 M
  • Annual Income, $ 4,863 M
  • 60-Month Beta 0.57
  • Price/Sales 5.82
  • Price/Cash Flow 9.49
  • Price/Book 25.84
Trade ABBV with:

Options Overview Details

View History
  • Implied Volatility 16.42% ( -0.70%)
  • Historical Volatility 13.94%
  • IV Percentile 2%
  • IV Rank 6.58%
  • IV High 28.31% on 10/19/23
  • IV Low 15.58% on 09/01/23
  • Put/Call Vol Ratio 1.02
  • Today's Volume 1,943
  • Volume Avg (30-Day) 19,581
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 321,374
  • Open Int (30-Day) 351,472

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 2.34
  • Number of Estimates 3
  • High Estimate 2.40
  • Low Estimate 2.30
  • Prior Year 2.46
  • Growth Rate Est. (year over year) -4.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
162.67 +7.28%
on 02/01/24
178.92 -2.46%
on 02/16/24
+9.12 (+5.51%)
since 01/22/24
3-Month
137.65 +26.78%
on 11/29/23
178.92 -2.46%
on 02/16/24
+36.04 (+26.03%)
since 11/22/23
52-Week
130.96 +33.25%
on 06/28/23
178.92 -2.46%
on 02/16/24
+23.84 (+15.82%)
since 02/22/23

Most Recent Stories

More News
Is AbbVie Stock a Buy Now?

Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable.

ABBV : 175.25 (+0.06%)
CERE : 40.97 (+0.10%)
5 Forever Dividend Stocks to Build Your Portfolio

These five stocks are high quality and reliable.

HD : 367.94 (+1.05%)
KO : 60.89 (-0.57%)
JNJ : 158.94 (+0.16%)
ABBV : 175.25 (+0.06%)
MSFT : 409.41 (+1.80%)
3 Magnificent Growth Stocks to Buy Right Now

These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.

ABBV : 175.25 (+0.06%)
LLY : 770.00 (+3.23%)
VRTX : 420.48 (+0.20%)
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END

TNXP : 0.3370 (-3.69%)
PFE : 27.23 (-1.59%)
LLY : 770.00 (+3.23%)
ABBV : 175.25 (+0.06%)
MRK : 128.04 (-0.06%)
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

TNXP : 0.3370 (-3.69%)
PFE : 27.23 (-1.59%)
LLY : 770.00 (+3.23%)
ABBV : 175.25 (+0.06%)
MRK : 128.04 (-0.06%)
Unleash Gain Potential With 3 Pharma Stocks to Consider

With an increasing demand for treatments of chronic diseases, heightened investments in research and development, and the widespread integration of technology, the pharma industry is primed for success....

ABBV : 175.25 (+0.06%)
AMRX : 5.78 (+0.87%)
GSK : 41.98 (+1.06%)
Zoetis (ZTS): Analyzing Earnings for Potential Gains

Veterinary drugmaker Zoetis Inc. (ZTS) is all set to disclose its fiscal fourth-quarter earnings tomorrow. With the company boasting an impressive track record of consistently surpassing earnings expectations,...

ABBV : 175.25 (+0.06%)
GSK : 41.98 (+1.06%)
NVO : 123.82 (+2.39%)
ZTS : 190.79 (+1.28%)
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?

These incredible businesses have long histories of successes behind them, and more to come.

ABBV : 175.25 (+0.06%)
JNJ : 158.94 (+0.16%)
These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy

The drugmaker is handling its biggest obstacle yet relatively well.

AGN.AX : 0.550 (-4.35%)
ABBV : 175.25 (+0.06%)
AbbVie's VYALEV™ (foslevodopa/foscarbidopa solution) Available for the Treatment of Advanced Parkinson's Disease in Canada

VYALEV is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of advanced Parkinson's disease (aPD) in Canada....

ABBV : 175.25 (+0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi...

See More

Key Turning Points

3rd Resistance Point 179.80
2nd Resistance Point 178.21
1st Resistance Point 176.68
Last Price 175.25
1st Support Level 173.55
2nd Support Level 171.96
3rd Support Level 170.43

See More

52-Week High 178.92
Last Price 175.25
Fibonacci 61.8% 160.60
Fibonacci 50% 154.94
Fibonacci 38.2% 149.28
52-Week Low 130.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar